Genetic variations associated with drug resistance

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2715319

Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM 1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.

La présente invention concerne des procédés et des compositions pour déterminer si un cancer est résistant à un traitement par des agents antimitotiques, et notamment à un traitement par du T-DM1. Les procédés consistent à déterminer si le gène ABCC3 est amplifié et/ou surexprimé dans le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Genetic variations associated with drug resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetic variations associated with drug resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic variations associated with drug resistance will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2033119

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.